CBOE Global Markets is upgraded from Hold to Buy, supported by strong earnings and an attractive valuation discount. Read ...

Alphabet is rated Buy with a $325 12-month price target, reflecting 15% upside from current levels. Read more on GOOG stock ...

See why BYD looks undervalued despite revenue and margin pressure, with steady gross profit, low debt, and key China market ...

OpenAI ( OPENAI) has cut the target for its newest funding round by $10B at a time when the U.S. tech stocks are in a selloff ...

Aura Biosciences offers a fully funded ocular oncology play with a Phase 3 upside and limited financing risk. Click to read ...

Acumen Pharmaceuticals' lead Alzheimer's drug sabirnetug failed to show clinical efficacy in the ALTITUDE-AD trial. See why ...

Extreme Networks stock looks attractive after raising FY2027 guidance and strong Q1 results. Click here to read in detail ...

Antero Midstream expects high-single-digit adjusted EBITDA growth in Q4 2026 despite some curtailments. Click here to read ...

Blue-chip REITs look undervalued after the sell-off, with strong yields, rent growth, and rate-driven upside—read more now.

GoDaddy shares have surged, but slowing growth, AI doubts, debt risk, and rising competition weaken the outlook. Read why ...

Teva Pharmaceutical Industries is undergoing a strategic transformation, pivoting from generics to innovative ...

Charter Communications remains a Buy despite ongoing broadband declines and high leverage, with a compelling risk/reward ...